WS #10134

20:36→21:02 UTC

From 500 msgs · 5 key-dev

FDA advisory committee unanimously votes 9-0 that benefits of Moderna's mRNA-1010 seasonal flu vaccine outweigh risks for adults 50+.

Moderna Flu Vaccine FDA AdComm

FDA advisory committee unanimously votes 9-0 that benefits of Moderna's mRNA-1010 seasonal flu vaccine outweigh risks for adults 50+.